Adrian Kilcoyne
Adrian Kilcoyne publishes mostly in Public Health, Environmental and Occupational Health, Economics and Econometrics and Statistics and Probability, on topics such as Statistical Methods in Clinical Trials, Pharmaceutical Economics and Policy and Pharmaceutical Quality and Counterfeiting.
- World rank
- #3,106,146 of 7,710,434 ranked researchers
- Rank in United States
- #886,737 of 1,627,098
- Works
- 194
- Citations
- 437
- Citations per work
- 2.3
What does Adrian Kilcoyne research?
Adrian Kilcoyne's work is mostly in Medicine (15%), Economics, Econometrics and Finance (10%), Mathematics (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else11257.5%
- Health Sciences3015.4%
- Medicine3015.4%
- Social Sciences2010.3%
- Life Sciences178.7%
- Physical Sciences168.1%
- Mathematics168.1%
- 1Public Health, Environmental and Occupational Health11% of their works
- 2Economics and Econometrics10% of their works
- 3Statistics and Probability8% of their works
- 4Immunology5% of their works
- 5Oncology4% of their works
- 6Toxicology4% of their works
Research topics
- Statistical Methods in Clinical Trials
- Pharmaceutical Economics and Policy
- Pharmaceutical Quality and Counterfeiting
- Pharmacovigilance and Adverse Drug Reactions
- Health Systems, Economic Evaluations, Quality of Life
- Biosimilars and Bioanalytical Methods
- Meta-analysis and systematic reviews
- Biomedical Ethics and Regulation
Which keywords describe Adrian Kilcoyne's research?
The keywords of their largest research topics: Patient Safety, Adaptive Designs, False Discovery Rate, Drug Development Costs, Generic Drugs, Counterfeit Drugs, Substandard Medicines and Adverse Drug Reactions.
- Clinical Trials
- Meta-Analysis
- Biosimilars
- Cost-effectiveness Analysis
- Adverse Drug Reactions
- Counterfeit Drugs
- Drug Development Costs
- Adaptive Designs
- Patient Safety
- False Discovery Rate
- Generic Drugs
- Substandard Medicines
- Pharmacovigilance
- Quality of Life
- Immunogenicity
- PRISMA Statement
- Stem Cell Regulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Patient Safety422 topics
- Adaptive Designs321 topic
- False Discovery Rate321 topic
- Drug Development Costs301 topic
- Generic Drugs301 topic
- Counterfeit Drugs281 topic
- Substandard Medicines281 topic
- Adverse Drug Reactions221 topic
- Pharmacovigilance221 topic
- Cost-effectiveness Analysis201 topic
- Quality of Life201 topic
- Biosimilars171 topic
- Immunogenicity171 topic
- Meta-Analysis171 topic
- PRISMA Statement171 topic
- Clinical Trials141 topic
- Stem Cell Regulation141 topic
Where does Adrian Kilcoyne work?
Adrian Kilcoyne's main affiliation in the publication record is Humanigen (United States), United States.
How many publications and citations does Adrian Kilcoyne have?
OpenAlex counts 194 works and 437 citations for Adrian Kilcoyne, an h-index of 6, ranking #3,106,146 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Adrian Kilcoyne. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.